The so-called precisionFDA system will provide a forum for sharing data and software as well as deriving standards to enable NGS-based testing
DNANexus will handle data from CareDx's cell-free transplant assay as well as support its ongoing research and development activities.
Using funds from the California precision medicine initiative, the group will use its bioinformatics expertise to match patients to treatments in pediatric clinical trials.
The initiative aims to integrate clinical, genomic, environmental, and other data from patients to help determine disease mechanisms and develop precise therapies.
DNAnexus' platform will support data analysis and sharing for the third phase of the Encyclopedia of DNA Elements project.
The so-called HgV platform offers tools for analyzing high-throughput whole genome sequence data for precision medicine research and clinical applications
The 3000 Rice Genomes Project will use DNANexus' platform in effort to improve nutrition, climate tolerance, and disease resistance in rice.
In addition to the investment, WuXi NextCode is partnering with DNAnexus to offer cloud-based analysis infrastructure to customers in China.
Customers of both companies' cloud-based platforms will have access to their respective genome analysis and interpretation pipelines.
Under the terms of the agreement, Garvan Institute will use DNAnexus' platform to support a number of genomics-based research initiatives
A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.
The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.
University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.
In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.